Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$832M |
| 2 |
Johnson & Johnson
JNJ
|
+$706M |
| 3 |
Datadog
DDOG
|
+$549M |
| 4 |
Amazon
AMZN
|
+$442M |
| 5 |
Eli Lilly
LLY
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$1.22B |
| 2 |
AbbVie
ABBV
|
+$1.07B |
| 3 |
Advanced Micro Devices
AMD
|
+$817M |
| 4 |
Amgen
AMGN
|
+$706M |
| 5 |
Honeywell
HON
|
+$659M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.69% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.23% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
iRadimed
IRMD
$1.21B
| – | – |
-24,207
| Closed | -$1.22M |
|
|
LAZR
2552
DELISTED
Luminar Technologies
LAZR
| – | – |
-6,253
| Closed | -$84.3K |
|
2553
Lightwave Logic
LWLG
$851M
| – | – |
-48,701
| Closed | -$134K |
|
2554
Lyell Immunopharma
LYEL
$319M
| – | – |
-3,425
| Closed | -$94.2K |
|
2555
Methode Electronics
MEI
$471M
| – | – |
-16,190
| Closed | -$194K |
|
2556
Manitowoc
MTW
$500M
| – | – |
-15,545
| Closed | -$150K |
|
2557
MaxCyte
MXCT
$109M
| – | – |
-30,087
| Closed | -$117K |
|
2558
Neurogene
NGNE
$653M
| – | – |
-709,469
| Closed | -$29.8M |
|
2559
Nomad Foods
NOMD
$1.76B
| – | – |
-725,137
| Closed | -$13.8M |
|
2560
Nu Skin
NUS
$253M
| – | – |
-22,075
| Closed | -$163K |
|
2561
OPAL Fuels
OPAL
$64.7M
| – | – |
-21,727
| Closed | -$79.3K |
|
2562
Outfront Media
OUT
$5.82B
| – | – |
-63,407
| Closed | -$1.15M |
|
2563
POSCO
PKX
$14.9B
| – | – |
-50,000
| Closed | -$3.5M |
|
|
REFI
2564
Chicago Atlantic Real Estate Finance
REFI
$253M
| – | – |
-10,344
| Closed | -$160K |
|
2565
Rimini Street
RMNI
$458M
| – | – |
-113,306
| Closed | -$210K |
|
2566
Southern Copper
SCCO
$137B
| – | – |
-2,290
| Closed | -$249K |
|
|
SLN
2567
Silence Therapeutics
SLN
$539M
| – | – |
-1,087,228
| Closed | -$19.8M |
|
2568
SmartRent
SMRT
$197M
| – | – |
-49,626
| Closed | -$86.1K |
|
2569
Stoneridge
SRI
$200M
| – | – |
-11,777
| Closed | -$131K |
|
2570
Tecnoglass
TGLS
$1.97B
| – | – |
-60,886
| Closed | -$4.18M |
|
2571
Treace Medical Concepts
TMCI
$256M
| – | – |
-19,553
| Closed | -$113K |
|
2572
LendingTree
TREE
$565M
| – | – |
-4,600
| Closed | -$266K |
|
2573
Under Armour
UAA
$3B
| – | – |
-81,838
| Closed | -$730K |
|
2574
VirTra
VTSI
$33M
| – | – |
-17,705
| Closed | -$110K |
|
2575
York Water
YORW
$512M
| – | – |
-5,931
| Closed | -$222K |
|
Similar funds
Janus Henderson Group's Q4 2024 Portfolio in Review
As of Q4 2024, Janus Henderson Group held 2,620 positions worth $197B, up 0.7% from $195B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q4 2024 filing shows 92 new, 801 increased, 713 reduced and 96 closed positions. Its largest new stake was Lam Research: 10,967,975 shares worth $792M. The largest sale was Workday, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2024 buy was Lam Research: 10,967,975 shares worth $792M.
- Janus Henderson Group added most to Johnson & Johnson in Q4 2024, an estimated $706M increase.
- Janus Henderson Group's biggest Q4 2024 reduction was Workday, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Coca-Cola Europacific Partners in Q4 2024, selling an estimated $52.4M.
- Janus Henderson Group's ten largest holdings make up 32% of its $197B portfolio in Q4 2024.
- Janus Henderson Group opened 92 new positions and closed 96 in Q4 2024.
- Janus Henderson Group's portfolio value rose 0.7% quarter-over-quarter to $197B.
Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.